Good evening,

Woodside chief executive Peter Coleman said his company was "primed" to pursue deals when he handed down a record $US4 billion first-half loss today.

And one of those potential deals would no doubt be Chevron's up-for-sale stake in Australia's largest oil and gas project, where Woodside is seen as the most logical acquirer.

Chevron and its bankers at UBS blasted out a flyer for its one-sixth stake in the North West Shelf project this week and tonight we reveal its contents.

UBS has come up with an eight-point pitch for the project as well as supplying some key NWS statistics. We unveil all.

Meanwhile, there's another healthtech company lining up for the ASX boards following the lead of Aroa Biosurgery and 4DMedical, which both floated earlier this year.

Finally, we take a look at what KKR's next potential investment could be and mandates have started flying for Asahi's up-for-sale drinks portfolio.

Happy reading,

Sarah Thompson, Anthony Macdonald and Tim Boyd.

Street Talk Editors